Medicus Sciences Acquisition Corp. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance sheets

In millions of USD, except per-share amounts

	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021
Assets
Current Assets:
Cash
Prepaid expenses
Due from Sponsor
Total current assets
Investments held in Trust Account
Class A ordinary shares
Total investments held in Trust Account
Derivative asset - forward purchase agreement
Total Assets
Liabilities, Redeemable Ordinary Shares and Shareholders' Deficit
Current liabilities:
Accrued offering costs and expenses
Accrued expenses
Due to related party
Total current liabilities
Deferred underwriting commissions
Derivative liability - forward purchase agreement
Derivative liability - warrants
Total Liabilities
Class A ordinary shares subject to possible redemption, $0.0001 par value; 9,200,000 shares issued and outstanding at redemption value of $10.04 and $10.00 per share as of September 30, 2022,and December 31, 2021,respectively
Class A ordinary shares subject to possible redemption
Total class A ordinary shares subject to possible redemption, $0.0001 par value; 9,200,000 shares issued and outstanding at redemption value of $10.04 and $10.00 per share as of September 30, 2022,and December 31, 2021,respectively
Shareholders' Deficit:
Ordinary shares
Class A ordinary shares
Class A ordinary shares not subject to possible redemption
Total class A ordinary shares
Class B ordinary shares
Additional paid-in capital
Accumulated deficit
Class A ordinary shares
Class B ordinary shares
Total Shareholders' Deficit
Total Liabilities, Redeemable Ordinary Shares and Shareholders' Deficit

Comments